SCHEMBL29922398

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O

nearest known ligand 0.70

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	6/20	0.69

▸	PTH1R	Q03431	8/20	0.68

▸	KEAP1	Q14145	2/20	0.66

▸	GCGR	P47871	2/20	0.65

▸	RXFP1	Q9HBX9	1/20	0.65

▸	CXCR4	P61073	1/20	0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30874225	0.97	GLP1R (0.73)	GLP1RPTH1RGCGR
SCHEMBL30536952	0.96	GLP1R (0.70)	GLP1RPTH1RGCGR
SCHEMBL31759052	0.95	GLP1R (0.75)	GLP1RPTH1RGCGR
SCHEMBL30750752	0.95	GLP1R (0.73)	GLP1RGCGR
SCHEMBL29359393	0.94	GLP1R (0.76)	GLP1RPTH1RGCGR
SCHEMBL29376189	0.94	GLP1R (0.76)	GLP1RPTH1RGCGR
SCHEMBL29399148	0.94	GLP1R (0.76)	GLP1RPTH1RGCGR
Cecropin B SCHEMBL29355118	0.94	KEAP1 (0.69)	GLP1RPTH1RKEAP1GCGRRXFP1
Acetic Acid SCHEMBL29568059	0.94	GLP1R (0.75)	GLP1RPTH1RGCGRCXCR4
SCHEMBL30029354	0.94	GLP1R (0.68)	GLP1RPTH1RGCGRCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11446385-B2	Polymer derivatives having particular atom arrangements	NEKTAR THERAPEUTICS (US)	2022-09-20	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-11446385-B2	Polymer derivatives having particular atom arrangements	CD44, PIGO, PGLS	GLP1R 4435/4885PTH1R 3574/4885KEAP1 2581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.